Non-Viral TCR Gene Therapy

First posted Sep 25, 2019

Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

1 participants · First posted Apr 27, 2022

Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

12 participants · First posted Oct 26, 2006

TCR-1

820-TCR

MAGE A3 TCR

LION TCR PTE. LTD.

Singapore

TScan Therapeutics

United States

Immatics

Germany

Parse Biosciences Wins Patent Invalidation Case Against 10x Genomics in Single Cell Sequencing Dispute

Parse Biosciences Expands Global Single Cell Sequencing Access Through Strategic Service Provider Partnerships

Lion TCR Receives FDA IND Clearance for First-in-Class TCR-T Therapy Targeting Chronic Hepatitis B